Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

NCT07752979 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight

Interventions

DRUG: ABBV-295
DRUG: Placebo

Sponsor

AbbVie